Skip to content
Screener

Kodiak Sciences Inc KOD Retained Earnings

Retained Earnings at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$37.62B+11.7%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
-$1.28B-31.4%
KLR
Kalaris TherapeuticsKLRS
-$170.86M-34.8%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-$785.06M-25.8%
HRO
HarrowHROW
-$184.13M-8.8%
PVL
Palvella TherapeuticsPVLA
-$151.22M-48.4%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized;none issued
Common stock, $0.0001 par value – 490,000,000 shares authorized; 62,155,685 and 61,758,454 shares issued and outstanding, respectively66
Additional paid-in capital1,728,9581,716,082
Accumulated deficit(1,616,863)(1,558,705)
Total stockholders’ equity112,101157,383
Total liabilities and stockholders’ equity$306,006$351,533

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's retained earnings?
Kodiak Sciences Inc (KOD) reported retained earnings of -$1.62B in Q1 2026.
How has Kodiak Sciences Inc's retained earnings changed year-over-year?
Kodiak Sciences Inc's retained earnings decreased by 16.6% year-over-year, from -$1.39B to -$1.62B.
What is the long-term trend for Kodiak Sciences Inc's retained earnings?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's retained earnings has grown at a 39.9% compound annual growth rate (CAGR), from -$291.23M to -$1.56B.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about Kodiak Sciences Inc's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude